A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C
| Status: | Completed |
|---|---|
| Conditions: | Hepatitis |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | August 2011 |
| End Date: | October 2013 |
An International, Multi-Center Study Evaluating the Correlation of IL28B Genotypes With Patient Demographics and Disease Characteristics in Patients With Chronic Hepatitis C
This multicenter study will evaluate the correlation of interleukin 28B (IL28B) genotypes
with disease characteristics and demographics in treatment-naïve and treatment-experienced
chronic hepatitis C patients, including patients with HIV co-infection. There will be a
single study visit for testing.
with disease characteristics and demographics in treatment-naïve and treatment-experienced
chronic hepatitis C patients, including patients with HIV co-infection. There will be a
single study visit for testing.
Inclusion Criteria:
- Adult (according to local legislation) male or female patient
- Chronic hepatitis C (CHC)
- Patients naïve to CHC treatment or patients who received prior interferon-based
therapy for CHC for whom data on treatment received and treatment outcome is
available; information on fibrosis stage prior to previous treatment is also required
Exclusion Criteria:
- Co-infection with hepatitis B
- History or evidence of decompensated liver disease
- History of major organ transplantation with an existing functional graft (including
liver transplantation)
- End stage renal disease
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials